Exelixis, Inc.

NasdaqGS:EXEL

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Pharmaceuticals

Location

United States

Market Cap

USD 9.92 B

Share Price

USD 36.85

Avg Daily Volume

3,359,838

Change (1 day)

-0.23%

Change (1 year)

58.38%

Change (YTD)

10.68%

Exelixis, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending July 04, 2025: USD 772.03 M

Exelixis, Inc. Operating Cash Flow is USD 772.03 M for the Trailing 12 Months (TTM) ending July 04, 2025, a 144.08% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Exelixis, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 28, 2024 was USD 316.31 M, a -18.72% change year over year.
Exelixis, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 389.15 M, a 8.52% change year over year.
Exelixis, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending July 01, 2022 was USD 358.61 M, a 31.71% change year over year.
Exelixis, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending July 02, 2021 was USD 272.28 M, a -30.43% change year over year.